Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFLUENCE: intra-operative fluorescent c-Met tracer imaging in penile and tongue cancer
2019-003022-24Phase 2Active
- Sponsor
- Netherlands Cancer Institute
- Start
- Oct 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of emi-137 in penile cancer and lingual carcinoma, sponsored by Netherlands Cancer Institute. Primary endpoint: Feasibility of intraoperative tumor visualization. Started Oct 2019; status: active.
02
Drugs
emi-137
03
Conditions
penile cancerlingual carcinoma
Beyond the preview
Go deeper on 2019-003022-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003022-24.